UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 18, 2020
Accession Number: 0001104659-20-104500
Submission Type: POS AM
CIK: 0001541157
Company Name: Akari Therapeutics Plc
File Number: 333-239923